Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

CNBC | Breaking News
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal
This is a developing news story. Please check back for updates:
https://www.cnbc.com/2020/09/13/gilead-to-buy-cancer-drugmaker-immunomedics-in-21-billion-deal.html
5ad4d078b4f1a.png

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.